1,2,3-triazine scaffold as a potent biologically active moiety: A mini review

Mini-Reviews in Medicinal Chemistry

Volumn 14, Issue 1, 2014, Pages 72-83

  Kumar, Rajeev ^a   Singh, Amar Deep ^a   Singh, Jitendra ^a   Singh, Hariram ^a   Roy, R K ^a   Chaudhary, Anurag ^b  

^a Dr KNModi Institute of Pharmaceutical Education & Research Modinagar   (India)

^b MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

1,2,3 triazine; Anticancer activity; Antimicrobial activity; Antiprotozoal; In vivo

Indexed keywords

1, 2, 3 TRIAZINE DERIVATIVE; DNA; PROTEIN; RNA; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTIARTHRITIC ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIHISTAMINIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CHEMICAL STRUCTURE; CYTOTOXICITY; HUMAN; NEMATOCIDAL ACTIVITY; NEOPLASM; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; CELL PROLIFERATION; FUNGI; HUMANS; MOLECULAR STRUCTURE; TRIAZINES;

EID: 84896715232     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557513666140103111017     Document Type: Review

References (52)

1. Viswanatha, G. L.; Akinapally, N.; Shylaja, H.; Nandakumar, K.; Srinath, R.; Janardhanan, S. Analgesic, anti-inflammatory and antiarthritic activity of newly synthesized bicyclothieno 1, 2, 3-triazines. Macedon. J. Med. Sci., 2011, 4(2), 131-138.
2. Simons, J. K.; Saxton, M. R. Benzoguanamine. Organic syntheses Collective, 1963, 04, 78.
3. Saravanan, J.; Mohan, S.; Roy, J. J. Synthesis of some 3-substituted amino-4, 5-tetramethylene thieno[2, 3-d][1, 2, 3]-triazin-4(3H)-ones as potential antimicrobial agents. Eur. J. Med. Chem., 2010, 45, 4365-4369.
4. Migawa, M. T.; Drach, J. C.; Townsend, L. B. Design, Synthesis and antiviral activity of novel 4, 5-disubstituted 7-(-D-Ribofuranosyl) pyrrolo[2, 3-d][1, 2, 3]triazines and the novel 3-amino-5-methyl-1-(-D-ribofuranosyl)-and 3-amino-5-methyl-1-(2-deoxy--Dribofuranosyl)-1, 5-dihydro-1, 4, 5, 6, 7, 8-hexaazaacenaphthylene as analogues of triciribine. J. Med. Chem., 2005, 48, 3840-3851.
5. Roeowsky, A.; Forsch, R. A.; Morant, R. G. N-[4-[(3, 4-Dihydro-4-oxo-1, 2, 3-benzotriazin-6-yl)methyl]amino]benzoyl]-L-glutamic acid, A novel a-ring analogue of 2-desamino-5, 8-dideazafolic acid. J. Med. Chem., 1992, 35, 2626-2630.
6. Garutia, L.; Roberti, M.; Rossi, T.; Castelli, M.; Malagoli, M. Synthesis and antiproliferative activity of 3-substituted 1H-indole [3, 2-d]1, 2, 3-triazin-4 (3H)-ones. Eur. J. Med. Chem., 1998, 33, 43-46.
7. Diana, P.; Barraja, P.; Lauria, A.; Montalbano, A.; Almerico, A. M.; Dattolo, G.; Cirrincione, G. Pyrrolo[2, 1-c][1, 2, 4]triazines from 2-diazopyrroles: synthesis and antiproliferative activity. Eur. J. Med. Chem., 2002, 37, 267-272.
8. Sidwell, R. W.; Dixon, G. J.; Sellers, S. M.; Schabel, F. M. In vivo antiviral properties of biologically active compounds. Appl. Microbiol., 1968, 16(2), 370-392.
9. Falke. D.; Rada, B. 6-Azauridine as an inhibitor of the synthesis of Herpesvirus hominis. Acta virologica, 1970, 14(2), 115-123.
10. Creasey, W. A.; Fink, M. E.; Handschumacker R. E.; Calabresi, P. Clinical and pharmacological studies with 2', 3', 5'-triacetyl-6-azauridine. Cancer Res., 1963, 23, 444-453.
11. Walters, T. R., Aur, R. J. A.; Hernandez, K.; Vietti, T.; Pinkel, D. 6-Azauridine in combination chemotherapy of childhood acute myelocytic leukemia. Cancer, 1972, 29(4), 1057-1060.
12. Negwer, M. Organic hemical Drugs and Their Synonyms (an International Survey), Akademie, Berlin: 1987.
13. Sarkar, U.; Glaser, R.; Parsons, Z. D.; Barnes, C. L.; Gates, K. S. Synthesis, crystal structure, and rotational energy profile of 3-cyclopropyl-1, 2, 4-benzotriazine 1, 4-di-N-oxide. J. Chem. Crystallogr., 2010, 40(7), 624-629.
14. Kobari, K.; Takakura, I.; Nakatomi, M.; Sogame, S.; Uylangco, C. Antibiotic-resistant strains of E1 tor vibrio in the philippines and the use of furalazine for chemotherapy. Bull world health organ, 1970, 43(30), 365-371.
15. th edi.; Jaypee brothers medical publishers (P) Ltd: New Delhi, 2003.
16. th edi.; Wolters Kluwer Pvt Ltd: New Delhi, 2010.
17. Ucherek, M. M.; Wroblewska, J.; Modzelewskabanachiewicz, B.; Gospodarek, E. Biological activity of methyl 2-[5-oxo-3, 4-di-(2-pirydyl)-1, 4, 5, 6-tetrahydro-1, 2, 4-triazine-6-ylidene]acetate. Acta Polon. Pharm. Drug Res., 2008, 65(6), 789-791.
18. Rauf, A.; Sharma, S; Gangal, S. Microwave assisted efficient onepot synthesis of 3, 5, 6-trisubstituted-1, 2, 4-triazines from fatty acid hydrazides under solvent-free conditions and their antimicrobial activity. Arc. Org. Chem., 2007, 16, 137-147.
19. Afonso, C. A. M.; Lourenco, N. M. T.; Rosatella, A. D. A. Synthesis of 2, 4, 6-tri-substituted-1, 3, 5-triazines. Molecules, 2006, 11, 81-102.
20. Arya, K.; Dandia, A. Synthesis and cytotoxic activity of trisubstituted-1, 3, 5-triazines. Bioorg. Med. Chem. Lett., 2007, 17(12), 3298-3304.
21. Zheng, M.; Xu, C.; Ma, J.; Sun, Y.; Du, F.; Liu, H,; Lin, L.; Li, C.; Ding, J.; Chen, K.; Jiang, H. Synthesis and antitumor evaluation of a novel series of triaminotriazine analogs. Bioorg. Med. Chem., 2007, 15(4), 1815-1827.
22. Menicagli, R.; Samaritani, S.; Signore, G.; Vaglini, F.; Via, L. D. In vitro cytotoxic activities of 2-alkyl-4, 6-diheteroalkyl-1, 3, 5-triazines: new molecules in anticancer research. J. Med. Chem., 2004, 47, 4649-4652.
23. Kumar, R.; Gupta, L.; Pal, P.; Khan, S.; Singh, N.; Katiyar, S. B.; Meena, S.; Sarkar, J.; Sinha, S.; Kanaujiya, J. K.; Lochab, S.; Trivedi, A. K.; Chauhan, P. M. S. Synthesis and cytotoxicity evaluation of (tetrahydro--carboline)-1, 3, 5-triazine hybrids as anticancer agents. Eur. J. Med. Chem., 2010, 45, 2265-2276.
24. th edi.; New age international publishers: New Delhi, 2010.
25. Stukov, A. N.; Korasakov, M. V.; Khrapova, T. N.; Kilmaeva, N. E.; Kraiz, B. O. Effect of dioxadet on tumors transplanted to the brain. Vopr. Onkol., 1986, 32(10), 64-67.
26. Stukov, A. N.; Filov, V. A.; Konkov, S. A.; Ivin, B. V. The pharmacological properties of preparations from the aziridinyltriazine group. Eksp Klin Farmakol, 1996, 59(1), 58-60.
27. Bespalov, V. G.; Beliaeva, O. A.; Panchenko, A. V.; Stukov, A. N.; Gershanovich, M. L. Murazov, I. G.; Konkov, S. A.; Kilmaeva, N. E.; Krylova, I. M.; Mironiuk, T. A.; Latipova, D. K. Antitumor activity of dioxadet compared with cisplatin on ascetic ovarian tumor in rats. Vopr. Onkol., 2011, 57(6), 771-774.
28. Saczewski, F.; Bulakowska, A.; Bednarski, P.; Grunert, R. Synthesis, structure and anticancer activity of novel 2, 4-diamino-1, 3, 5-triazine derivatives. Eur. J. Med. Chem., 2006, 41, 219-225.
29. Dhainaut, A.; Regnier, G.; Tizot, A.; Pierre, A.; Leonce, S.; Guilbaud, N.; Kraus-Berthier, L.; Atassi, G. New purines and purine analogs as modulators of multidrug resistance. J. Med. Chem., 1996, 39(20), 4099-4108.
30. Oh, K. S.; Oh, B. K.; Park, C. H.; Seo, H. W.; Kang, N. S.; Lee, J. H.; Lee, J. S.; Lee, B. H. Cardiovascular effects of a novel selective Rho kinase inhibitor, 2-(1H-indazole-5-yl)amino-4-methoxy-6-piperazinotriazine (DW1865). Eur. J. Pharmacol., 2013, 702, 218-226.
31. Ali M. M., Mahmoud A. E., Rashad A. E. Inhibition of human MCF-7 breast cancer growth by free radicals enhancement of polycondensed thienopyrimidine derivatives. Asian J. Pharm. Clin. Res., 2011, 4(1), 118-122.
32. Lv, J. L.; Wang, R.; Liu, D.; Guo, G.; Jing, Y. K.; Zhao, L. X. Design, synthesis, and antitumor activities of some novel substituted 1, 2, 3-benzotriazines. Molecules, 2008, 13(6), 1427-1440.
33. Cirrincione, G.; Almerico, A. M.; Barraja, P.; Diana, P.; Lauria, A.; Passannanti, A.; Musiu, C.; Pani, A.; Murtas, P.; Minnei, C.; Marongiu, M. E.; Colla, P. L. Derivatives of the new ring system indolo[1, 2-c]benzo[1, 2, 3]triazine with potent antitumor and antimicrobial activity. J. Med. Chem., 1999, 42(14), 2561-2568.
34. Diguarher, T. L.; Chollet, A. M.; Bertrand, M.; Hennig, P.; Raimbaud, E.; Sabatini, M.; Guilbaud, N.; Pierre, A.; Tucker, G. C.; Casara, P. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors. J. Med. Chem., 2003, 46(18), 3840-3852.
35. Hunt, J. C. A.; Briggs, E.; Clarke, E. D.; Whittingham, W. G. Synthesis and SAR studies of novel antifungal 1, 2, 3-triazines. Bioorg. Med. Chem. Lett., 2007, 17(18), 5222-5226.
36. Bondock, S.; Rabie, R.; Etman, H. A.; Fadda, A. A. Synthesis and antimicrobial activity of some new heterocycles incorporating antipyrine moiety. Eur. J. Med. Chem., 2008, 43(10), 2122-2129.
37. Patel, T. M.; Patel, A. M. Synthesis and antimicrobial activity of newly azetidinone derivatives. Pharm. Lett., 2012, 4(2), 579-583.
38. Patel, T. M.; Patel, A. M. Synthesis and biological screening of novel heterocyclic compounds. J. Chem., Biol. Phys. Sci., 2012, 2(4), 1717-1723.
39. Quintela, J. M., Peinador, C.; Gonzalez, L.; Iglesias, R.; Parama, A.; Alvarez, F.; Sanmartin, M. L.; Riguera, R. Piperazine N-substituted naphthyridines, pyridothienopyrimidines and pyridothienotriazines: new antiprotozoals active against Philasterides dicentrarchi. Eur. J. Med. Chem., 2003, 38, 265-275.
40. Kiuchi, F.; Nishizawa, S.; Kawanishi, H.; Kinoshita, S.; Ohsima, H.; Uchitani, A.; Sekino, N.; Ishida, M.; Kondo, K.; Tsuda, Y. Nematocidal activity of long alkyl chain amides, amines, and their derivatives on dog roundworm larvae. Chem. Pharm. Bull., 1992, 40(12), 3234-3244.
41. Feldmesser, J.; Thompson, M. J.; Robbins, W. E.; Sponaugle, R. P. Nematidical activity of secondary and tertiary alkyl amides and amines. Experientia., 1976, 32(4), 466-467.
42. Nishiwaki, K.; Okamoto, A.; Matsuo, K.; Hayase, Y.; Masaki, S.; Hasegawa, R.; Ohba, K. Tetrahydrobenzotriazines as a new class of nematocide. Bioorg. Med. Chem., 2007, 15(3), 1341-1345.
43. Krawczyk, S.; Migawa, M. T.; Drach, J. C.; Townsend, L. B. Synthesis of 4-substituted imidazo[4, 5-d][1, 2, 3]triazine (2-Azapurine) nucleosides. Nucleosides, Nucleotides Nucleic Acids., 2000, 19(1&2), 39-68.
44. Srinath R.; Vithlani, P. D.; Saravanan J.; Jagdale, P. S.; Raghav, P.; Shenoy, A. Synthesis and evaluation of anti-depressant like activity of some novel thieno 1, 2, 3-triazine-4-ones. Int. J. Res. Pharm. Sci., 2010, 1(2), 143-150.
45. Quintela, J. M.; Peinador, C.; Veiga, M. C.; Botana, L. M.; Alfonso, A.; Riguera, R. Synthesis, antihistaminic and cytotoxic activity of pyridotheino-and pyridoditheinotriazines. Eur. J. Med. Chem., 1998, 33, 887-897.
46. Viswanatha, G. L.; Priyadarshini, B. J.; Krishnadas, N.; Janardhanan, S.; Rangappa, S.; Hanumanthappa, S. Synthesis and antihistaminic activity of 3H-benzo [4, 5]thieno[2, 3-d][1, 2, 3]triazin-4-ones. Saudi Pharm. J., 2012, 20, 45-52.
47. Quintela, J. M.; Peinador, C.; Gonzalez, L. M; Riguera, R.; Rioja, I.; Terencio, M. C.; Ubeda, A.; Alcaraz, M. J. Synthesis and pharmacological evaluation of some 8-cyanopyrido[3', 2': 4, 5] thieno[3, 2-d]triazine derivatives as inhibitors of nitric oxide and eicosanoid biosynthesis. J. Med. Chem., 1999, 42, 4720-4724.
48. Youssefyeh, R. D.; Brown, R. E.; Wilson, J.; Shah, U.; Jones, H.; Loev, B.; Khandwala, A.; Leibowitz, M. J.; Sonnino-Goldma, P. Pyrido[3', 2': 4, 5]thieno[3, 2-d]-N-triazines: A new series of orally active antiallergic agents. J. Med. Chem., 1984, 27(12), 1639-1643.
49. Li, H.; Tatlock, J.; Linton, A.; Gonzalez, J.; Jewell, T.; Patel, L.; Ludlum, S.; Drowns, M.; Rahavendran, S. V.; Skor, H.; Hunter, R.; Shi, S. T.; Herlihy, K. J.; Parge, H.; Hickey, M.; Yu, X.; Chau, F.; Nonomiya, J.; Lewis, C. Discovery of (R)-6-cyclopentyl-6-(2-(2, 6-diethylpyridin-4-yl)ethyl)-3-(5, 7-dimethyl-[1, 2, 4]triazolo[1, 5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5, 6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. J. Med. Chem., 2009, 52(5), 1255-1258.
50. Gueto, C.; Ruiz, J. L.; Torres, J. E.; Mendez, J.; Vivas-Reyes, R. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA. Bioorg. Med. Chem., 2008, 16(5), 2439-2447.
51. Noronha, G.; Barrett, K.; Cao, J.; Dneprovskaia, E.; Fine, R.; Gong, X.; Gritzen, C.; Hood, J.; Kang, X.; Klebansky, B.; Li, G.; Liao, W.; Lohse, D.; Mak, C. C.; McPherson, A.; Palanki, M. S.; Pathak, V. P.; Renick, J.; Soll, R.; Splittgerber, U.; Wrasidlo, W.; Zeng, B.; Zhao, N.; Zhou, Y. Discovery and preliminary structureactivity relationship studies of novel benzotriazine based compounds as Src inhibitors. Bioorg. Med. Chem. Lett., 2006, 16(21), 5546-5550.
52. Hess-Stumpp, H.; Haberey, M.; Thierauch, K. H. PTK 787/ZK 222584, a tyrosine kinase inhibitor of all known VEGF receptors, represses tumor growth with high efficacy. Chembiochem, 2005, 6(3), 550-557.